Literature DB >> 12010627

Autism and gastrointestinal symptoms.

Karoly Horvath1, Jay A Perman.   

Abstract

Autism is a collection of behavioral symptoms characterized by dysfunction in social interaction and communication in affected children. It is typically associated with restrictive, repetitive, and stereotypic behavior and manifests within the first 3 years of life. The cause of this disorder is not known. Over the past decade, a significant upswing in research has occurred to examine the biologic basis of autism. Recent clinical studies have revealed a high prevalence of gastrointestinal symptoms, inflammation, and dysfunction in children with autism. Mild to moderate degrees of inflammation were found in both the upper and lower intestinal tract. In addition, decreased sulfation capacity of the liver, pathologic intestinal permeability, increased secretory response to intravenous secretin injection, and decreased digestive enzyme activities were reported in many children with autism. Treatment of digestive problems appears to have positive effects on autistic behavior. These new observations represent only a piece of the unsolved autism "puzzle" and should stimulate more research into the brain-gut connection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12010627     DOI: 10.1007/s11894-002-0071-6

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  23 in total

1.  Effect of two synthetic alpha-gliadin peptides on lymphocytes in celiac disease: identification of a novel class of opioid receptors.

Authors:  L Graf; K Horvath; E Walcz; I Berzetei; J Burnier
Journal:  Neuropeptides       Date:  1987 Feb-Mar       Impact factor: 3.286

2.  Malabsorption and cerebral dysfunction: a multivariate and comparative study of autistic children.

Authors:  M S Goodwin; M A Cowen; T C Goodwin
Journal:  J Autism Child Schizophr       Date:  1971 Jan-Mar

3.  Novel opioid peptides derived from casein (beta-casomorphins). I. Isolation from bovine casein peptone.

Authors:  V Brantl; H Teschemacher; A Henschen; F Lottspeich
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1979-09

4.  Abnormal intestinal permeability in children with autism.

Authors:  P D'Eufemia; M Celli; R Finocchiaro; L Pacifico; L Viozzi; M Zaccagnini; E Cardi; O Giardini
Journal:  Acta Paediatr       Date:  1996-09       Impact factor: 2.299

5.  Demonstration of high opioid-like activity in isolated peptides from wheat gluten hydrolysates.

Authors:  F R Huebner; K W Lieberman; R P Rubino; J S Wall
Journal:  Peptides       Date:  1984 Nov-Dec       Impact factor: 3.750

6.  Novel opioid peptides derived from human beta-casein: human beta-casomorphins.

Authors:  V Brantl
Journal:  Eur J Pharmacol       Date:  1984-10-30       Impact factor: 4.432

7.  Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation.

Authors:  J Bertrand; A Mars; C Boyle; F Bove; M Yeargin-Allsopp; P Decoufle
Journal:  Pediatrics       Date:  2001-11       Impact factor: 7.124

Review 8.  Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12-13, 2000.

Authors:  N A Halsey; S L Hyman
Journal:  Pediatrics       Date:  2001-05       Impact factor: 7.124

9.  Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study.

Authors:  M P Bouvard; M Leboyer; J M Launay; C Recasens; M H Plumet; D Waller-Perotte; F Tabuteau; D Bondoux; M Dugas; P Lensing
Journal:  Psychiatry Res       Date:  1995-10-16       Impact factor: 3.222

10.  Plasma beta-casomorphin-7 immunoreactive peptide increases after milk intake in newborn but not in adult dogs.

Authors:  M Singh; C L Rosen; K J Chang; G G Haddad
Journal:  Pediatr Res       Date:  1989-07       Impact factor: 3.756

View more
  50 in total

Review 1.  Immune dysfunction in autism: a pathway to treatment.

Authors:  Milo Careaga; Judy Van de Water; Paul Ashwood
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

2.  Dietary adequacy of Egyptian children with autism spectrum disorder compared to healthy developing children.

Authors:  Nagwa A Meguid; Mona Anwar; Geir Bjørklund; Adel Hashish; Salvatore Chirumbolo; Maha Hemimi; Eman Sultan
Journal:  Metab Brain Dis       Date:  2017-01-10       Impact factor: 3.584

3.  Psychophysiological Associations with Gastrointestinal Symptomatology in Autism Spectrum Disorder.

Authors:  Bradley J Ferguson; Sarah Marler; Lily L Altstein; Evon Batey Lee; Jill Akers; Kristin Sohl; Aaron McLaughlin; Kaitlyn Hartnett; Briana Kille; Micah Mazurek; Eric A Macklin; Erin McDonnell; Mariah Barstow; Margaret L Bauman; Kara Gross Margolis; Jeremy Veenstra-VanderWeele; David Q Beversdorf
Journal:  Autism Res       Date:  2016-06-20       Impact factor: 5.216

4.  Can urinary indolylacroylglycine levels be used to determine whether children with autism will benefit from dietary intervention?

Authors:  Julie Wilson; Barry Wright; Sandra Jost; Robert Smith; Helen Pearce; Sally Richardson
Journal:  Pediatr Res       Date:  2016-11-23       Impact factor: 3.756

5.  Behavioral Phenotype of ASD Preschoolers with Gastrointestinal Symptoms or Food Selectivity.

Authors:  Margherita Prosperi; Elisa Santocchi; Giulia Balboni; Antonio Narzisi; Margherita Bozza; Francesca Fulceri; Fabio Apicella; Roberta Igliozzi; Angela Cosenza; Raffaella Tancredi; Sara Calderoni; Filippo Muratori
Journal:  J Autism Dev Disord       Date:  2017-11

6.  A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder.

Authors:  Benjamin L Handen; Raun D Melmed; Robin L Hansen; Michael G Aman; David L Burnham; Jon B Bruss; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2009-01-16

7.  Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism.

Authors:  S Jill James; Stepan Melnyk; George Fuchs; Tyra Reid; Stefanie Jernigan; Oleksandra Pavliv; Amanda Hubanks; David W Gaylor
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

8.  Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines.

Authors:  Tewarit Sarachana; Rulun Zhou; Guang Chen; Husseini K Manji; Valerie W Hu
Journal:  Genome Med       Date:  2010-04-07       Impact factor: 11.117

9.  Oxytocin modulates markers of the unfolded protein response in Caco2BB gut cells.

Authors:  Benjamin Y Klein; Hadassah Tamir; David L Hirschberg; Sara B Glickstein; Robert J Ludwig; Martha G Welch
Journal:  Cell Stress Chaperones       Date:  2013-11-06       Impact factor: 3.667

10.  Defective oxytocin function: a clue to understanding the cause of autism?

Authors:  Fiorella Gurrieri; Giovanni Neri
Journal:  BMC Med       Date:  2009-10-22       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.